Provided by Tiger Trade Technology Pte. Ltd.

TJ DaRenTang USD

3.050
0.000
Volume:93.70K
Turnover:285.54K
Market Cap:2.35B
PE:7.44
High:3.070
Open:3.070
Low:3.030
Close:3.050
52wk High:3.750
52wk Low:2.052
Shares:770.00M
Float Shares:421.34M
Volume Ratio:0.36
T/O Rate:0.02%
Dividend:0.71
Dividend Rate:23.17%
EPS(TTM):0.410
EPS(LYR):2.770
ROE:27.47%
ROA:5.92%
PB:2.12
PE(LYR):1.10

Loading ...

Tianjin Pharmaceutical Da Ren Tang Group Approves FY2025 Reports, Profit Distribution and IPT Mandates at AGM

SGX Filings
·
Jun 03

Tianjin Pharmaceutical Da Ren Tang Sets Jun, 10 2026 Online Briefing for FY2025 and Q1 2026 Results

SGX Filings
·
Jun 02

Chinese State-Backed Entities to Dispose of Stake in Tianjin Pharmaceutical Da Ren Tang Unit via Public Tender

MT Newswires
·
May 20

Tianjin Pharmaceutical Da Ren Tang Group Notes Planned Sale of Upstream Shareholder

SGX Filings
·
May 19

Tianjin Pharmaceutical Da Ren Tang Group issues April update on subsidiary’s bankruptcy

SGX Filings
·
Apr 30

Singapore Shares Surge More Than 1% as DBS Books Record Total Income

MT Newswires
·
Apr 30

Tianjin Pharmaceuticals Da Ren Tang's Attributable Profit Jumps 13% in Q1; Shares Up 5%

MT Newswires
·
Apr 30

Stock Track | TJ DaRenTang USD Soars 3.12% Intraday on Strong Q1 Earnings and New Strategic Plan

Stock Track
·
Apr 30

Tianjin Pharmaceutical Da Ren Tang Board Clears Q1 FY2026 Results, Adopts 2026 Efficiency Plan and Ends Equity Custody Agreement

SGX Filings
·
Apr 29

Tianjin Pharmaceutical Da Ren Tang reviews 2025 targets, adopts new 2026 action plan

SGX Filings
·
Apr 29

Tianjin Pharma Da Ren Tang Q1 net profit rises to RMB423 million on stronger TCM sales

SGX Filings
·
Apr 29

Tianjin Pharmaceutical Da Ren Tang Group Proposes New Independent Director

SGX Filings
·
Apr 16

Tianjin Pharmaceutical Da Ren Tang seeks green light for about 586 million Singapore dollars of new guarantees

SGX Filings
·
Apr 02

Singapore Shares Remain in Red Amid Soaring Energy Costs; Rex International Plunges 20%

MT Newswires
·
Mar 31

Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Down 4% in 2025

MT Newswires
·
Mar 31

Stock Track | TJ DaRenTang USD Soars 3.65% Intraday on Strong Profitability Metrics and New Shareholder Return Plan

Stock Track
·
Mar 31

Tianjin Pharmaceutical Da Ren Tang proposes S$589 million guarantees for affiliates

SGX Filings
·
Mar 30

Tianjin Pharmaceutical Da Ren Tang releases semi-annual risk report on group finance subsidiary

SGX Filings
·
Mar 30

Tianjin Pharmaceutical Da Ren Tang Appoints New Representative for A-Share Placement Oversight

SGX Filings
·
Mar 24

Tianjin Pharmaceutical Da Ren Tang Group Provides February Update on Subsidiary Bankruptcy

SGX Filings
·
Feb 27